Common Contracts
4 similar Transition Agreement contracts by SQZ Biotechnologies Co
Transition AgreementTransition Agreement • November 8th, 2023 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances)
This Transition Agreement (the “Agreement”) is made as of October 3, 2023 (the “Notice Date”), by and between SQZ Biotechnologies Company (the “Company”) and Marshelle Smith Warren (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
Transition AgreementTransition Agreement • November 8th, 2023 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances)
This Transition Agreement (the “Agreement”) is made as of October 3, 2023 (the “Notice Date”), by and between SQZ Biotechnologies Company (the “Company”) and Richard Capasso (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
Transition AgreementTransition Agreement • November 8th, 2023 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances)
This Transition Agreement (the “Agreement”) is made as of October 3, 2023 (the “Notice Date”), by and between SQZ Biotechnologies Company (the “Company”) and Howard Bernstein, M.D., Ph.D. (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
Transition AgreementTransition Agreement • November 8th, 2023 • SQZ Biotechnologies Co • Biological products, (no disgnostic substances)
This Transition Agreement (the “Agreement”) is made as of October 3, 2023 (the “Notice Date”), by and between SQZ Biotechnologies Company (the “Company”) and Lawrence Knopf (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
